Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents

References

• Kvien TK, Glennås A, Knudsrød OG, Smedstad LM, Mowinckel P, Førre Ø. The prevalence and severity of rheumatoid arthritis in Oslo: results from a county register and a population survey. Scand J Rheumatol 1997;26:412–8.
   PubMed Web of Science ®Google Scholar
• Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 2000;27:1386–9.
   PubMed Web of Science ®Google Scholar
• Madland TM, Apalset EM, Johannessen AE, Rossebö B, Brun JG. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 2005;32:1918–22.
   PubMed Web of Science ®Google Scholar
• Hoff M, Gulati AM, Romundstad PR, Kavanaugh A, Haugeberg G. Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trøndelag Health Study (HUNT). Ann Rheum Dis 2015;74:60–4.
   PubMed Web of Science ®Google Scholar
• Nossent JC, Gran JT. Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway. Scand J Rheumatol 2009;38:251–5.
   PubMed Web of Science ®Google Scholar
• Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in northern Norway. Arthritis Rheum 2005;53:850–5.
   PubMed Web of Science ®Google Scholar
• Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 1985;44:359–67.
   PubMed Web of Science ®Google Scholar
• Putrik P, Ramiro S, Kvien TK, Sokka T, Pavlova M, Uhlig T, et al. Inequities in access to biologic and synthetic DMARDs across 46 European countries. Annals Rheum Dis 2014;73:198–206.
   PubMed Web of Science ®Google Scholar
• Kaló Z, Vokó Z, Östör A, Clifton-Brown E, Vasilescu R, Battersby A, et al. Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. J Mark Access Health Policy 2017;5:1345680.
   Google Scholar
• Glintborg B, Lindström U, Aaltonen K, Kristianslund EK, Gudbjornsson B, Chatzidionysiou K, et al. Biological treatment in ankylosing spondylitis in the Nordic countries during 2010–2016: a collaboration between five biological registries. Scand J Rheumatol 2018;47:465–74.
   PubMed Web of Science ®Google Scholar
• Lie E, Fagerli KM, Mikkelsen K, Rødevand E, Lexberg Å, Kalstad S, et al. First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register. Ann Rheum Dis 2014;73:1905–6.
   PubMed Web of Science ®Google Scholar
• Mangerud W, Kjelvik M, Krokan T. Aktivitetsdata for somatisk spesialisthelsetjeneste 2017: norsk pasientregister [in Norwegian]. Helsedirektoratet. IS-2711. 2018. Cited 2021 Jun 1. Available from: https://www.helsedirektoratet.no/rapporter/aktivitetsdata-for-somatisk-spesialisthelsetjeneste/Aktivitetsdata%20for%20somatisk%20spesialisthelsetjeneste%202017.pdf/_/attachment/inline/ec8ed607-d173-4e5f-9489-8264a93231ad:949f3925cf6df6c4a1dca4d5e147282b1a47dc9a/Aktivitetsdata%20for%20somatisk%20spesialisthelsetjeneste%202017.pdf
   Google Scholar
• Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;68:777–83.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009;68:770–6.
   PubMed Web of Science ®Google Scholar
• Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665–73.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Dean LE, Jones GT, Macdonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 2014;53:650–7.
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009;11:229.
   PubMed Web of Science ®Google Scholar
• Scotti L, Franchi M, Marchesoni A, Corrao G. Prevalence and incidence of psoriatic arthritis: a systematic review and meta-analysis. Semin Arthritis Rheum 2018;48:28–34.
   PubMed Web of Science ®Google Scholar
• Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin North Am 2012;38:441–76.
   PubMed Web of Science ®Google Scholar
• Safiri S, Kolahi AA, Hoy D, Smith E, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. Annals Rheum Dis 2019;78:1463–71.
   PubMed Web of Science ®Google Scholar
• Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int 2021;41:863–77.
   PubMed Web of Science ®Google Scholar
• Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis 2017;76:1591–7.
   PubMed Web of Science ®Google Scholar
• Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 2011;70:624–9.
   PubMed Web of Science ®Google Scholar
• Exarchou S, Lindström U, Askling J, Eriksson JK, Forsblad-d’Elia H, Neovius M, et al. The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study. Arthritis Res Ther 2015;17:118.
   PubMed Web of Science ®Google Scholar
• Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB. Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 2017;37:1551–7.
   PubMed Web of Science ®Google Scholar
• Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 2000;12:239–47.
   PubMed Web of Science ®Google Scholar
• Bae SC, Lee YH. Causal relationship between years of education and the occurrence of rheumatoid arthritis. Postgrad Med J 2019;95:378–81.
   PubMed Web of Science ®Google Scholar
• Kurtze N, Eikemo TA, Kamphuis CBM. Educational inequalities in general and mental health: differential contribution of physical activity, smoking, alcohol consumption and diet. Eur J Public Health 2013;23:223–9.
   PubMed Web of Science ®Google Scholar
• Hedenstierna L, Bellocco R, Ye W, Adami HO, Åkerstedt T, Trolle Lagerros Y, et al. Effects of alcohol consumption and smoking on risk for RA: results from a Swedish prospective cohort study. RMD Open 2021;7:e001379.
   PubMed Web of Science ®Google Scholar
• Solmaz D, Eder L, Aydin SZ. Update on the epidemiology, risk factors, and disease outcomes of psoriatic arthritis. Best Pract Res Clin Rheumatol 2018;32:295–311.
   PubMed Web of Science ®Google Scholar
• Ogdie A, Weiss P. The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am 2015;41:545–68.
   PubMed Web of Science ®Google Scholar
• Johnsen SS, Bakland G, Nossent JC. The distribution of HLA-B27 subtype in patients with ankylosing spondylitis in Northern Norway. Scand J Rheumatol 2014;43:296–300.
   PubMed Web of Science ®Google Scholar
• Johnsen K, Gran JT, Dale K, Husby G. The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps). J Rheumatol 1992;19:1591–4.
   PubMed Web of Science ®Google Scholar
• Putrik P, Ramiro S, Lie E, Keszei AP, Kvien TK, van der Heijde D, et al. Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD. Rheumatology (Oxford) 2016;55:1217–24.
   PubMed Web of Science ®Google Scholar
• Tatangelo M, Tomlinson G, Paterson JM, Ahluwalia V, Kopp A, Gomes T, et al. Association of patient, prescriber, and region with the initiation of first prescription of biologic disease-modifying antirheumatic drug among older patients with rheumatoid arthritis and identical health insurance coverage. JAMA Netw Open 2019;2:e1917053.
   PubMed Web of Science ®Google Scholar
• Kim G, Barner JC, Rascati K, Richards K. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. J Manag Care Spec Pharm 2015;21:401–7.
   PubMed Web of Science ®Google Scholar
• Radovits BJ, Fransen J, Eijsbouts A, van Riel PL, Laan RF. Missed opportunities in the treatment of elderly patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:906–10.
   PubMed Web of Science ®Google Scholar
• Borren NZ, Ananthakrishnan AN. Safety of biologic therapy in older patients with immune-mediated diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2019;17:1736–1743.e4.
   PubMed Web of Science ®Google Scholar
• Armagan B, Sari A, Erden A, Kilic L, Erdat EC, Kilickap S, et al. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: single center real life results. Medicine (Baltimore) 2018;97:e9930.
   PubMed Web of Science ®Google Scholar
• Ortolan A, van Lunteren M, Ramiro S, Ramonda R, Landewé RBM, Dagfinrud H, et al. Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort. Arthritis Res Ther 2018;20:218.
   PubMed Web of Science ®Google Scholar
• Lahaye C, Tatar Z, Dubost JJ, Tournadre A, Soubrier M. Management of inflammatory rheumatic conditions in the elderly. Rheumatology (Oxford) 2019;58:748–64.
   PubMed Web of Science ®Google Scholar
• Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clin Rheumatol 2019;38:625–34.
   PubMed Web of Science ®Google Scholar
• Villani AP, Rouzaud M, Sevrain M, Barnetche T, Paul C, Richard MA, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol 2015;73:242–8.
   PubMed Web of Science ®Google Scholar
• Löfvendahl S, Theander E, Svensson Å, Carlsson KS, Englund M, Petersson IF. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden – a population-based register study. PLoS One 2014;9:e98024.
   PubMed Web of Science ®Google Scholar
• Lindström U, Exarchou S, Sigurdardottir V, Sundström B, Askling J, Eriksson JK, et al. Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register. Scand J Rheumatol 2015;44:369–76.
   PubMed Web of Science ®Google Scholar
• Paltta J, Heikkilä H, Pirilä L, Eklund K, Huhtakangas J, Isomäki P, et al. The validity of rheumatoid arthritis diagnoses in Finnish biobanks. Scand J Rheumatol 2021 ;1–9.
   PubMed Web of Science ®Google Scholar
• Eriksson JK, Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J. Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration. Arthritis Care Res (Hoboken) 2013;65:870–8.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, et al. Diagnostic prevalence of ankylosing spondylitis using computerized health care data, 1996 to 2009: underrecognition in a US Health Care Setting. Perm J 2016;20:15–151.
   PubMedGoogle Scholar
• Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol 2018;14:363–71.
   PubMed Web of Science ®Google Scholar